Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2022-03-18 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
独立董事关于2021年度相关事项及第四届董事会第三十三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report on various matters related to the company's 2021 fiscal year and the 33rd meeting of the 4th board of directors. It covers internal control self-evaluation, audit report review, fundraising usage, related party transactions, share repurchase plan, stock option cancellation, insurance purchase, donations, and profit distribution proposal. The document is a detailed review and opinion on these corporate governance and financial matters rather than the full annual report or audit report itself. It does not contain full financial statements or comprehensive financial data but rather independent opinions on specific corporate governance and financial issues. The document length is 3553 characters, which is relatively short and more consistent with a governance or board-related opinion document. Therefore, the best fitting category is Board/Management Information (MANG), as it relates to board opinions and approvals on key company matters.
2022-03-18 Chinese
2021年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2021年度监事会工作报告" which translates to "2021 Supervisory Board Work Report" of Yunnan Watson Biotechnology Co., Ltd. It details the supervisory board's activities, meetings, and oversight of company operations, financials, internal controls, and compliance during the 2021 fiscal year. It includes references to audit reports, financial reviews, and internal control evaluations but does not itself contain full financial statements or detailed financial data. The document is a report on the supervisory board's work and oversight rather than a full annual report or audit report. It is not a short announcement or certification but a substantive report on supervisory activities. Therefore, the best fitting category is Audit Report / Information (AR), as it relates to audit and supervisory oversight information without being the full annual report (10-K). The document length (3650 characters) is relatively short but contains detailed supervisory content, not just an announcement, so it is not RPA or RNS. FY 2021
2022-03-18 Chinese
2021年度独立董事述职报告（黄伟民）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report" for the year 2021 from a specific independent director of the company. It details the director's attendance at board meetings, independent opinions on various board resolutions, participation in committees, and efforts to protect shareholder interests. The content focuses on governance, oversight, and compliance activities rather than financial results or audit opinions. It is a detailed report on the director's management and governance role rather than a financial report, audit report, or announcement. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management activities and reports on their duties and changes. The document is not an Annual Report, Audit Report, or any other financial or regulatory filing. Therefore, the classification is MANG with high confidence.
2022-03-18 Chinese
监事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 25th meeting of the 4th Supervisory Board of Yunnan Watson Biotechnology Co., Ltd. It includes approvals of the 2021 annual supervisory board work report, audited financial report, annual report, internal control self-evaluation report, fundraising usage report, profit distribution plan, share repurchase plan, stock option cancellation, purchase of director and officer liability insurance, and donation plan. The document contains voting results and references to reports available on the designated disclosure website but does not itself contain the full annual report or financial statements. The focus is on the supervisory board's meeting resolutions and approvals, which is typical of a Board/Management Information filing. The document is not a full annual report (10-K), nor is it a simple announcement of a report publication (RPA). It is not a call transcript, earnings release, or other categories. Therefore, the best classification is Board/Management Information (MANG). The document length (6911 characters) supports it being a substantive meeting resolution announcement rather than a brief notice.
2022-03-18 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 33rd meeting of the 4th Board of Directors of Yunnan Watson Biotechnology Co., Ltd. It includes approvals of various reports such as the 2021 President's Work Report, 2021 Board Work Report, audited financial report, financial statements, annual report, internal control self-evaluation report, social responsibility report, profit distribution plan, and a share repurchase plan. The document also discusses authorizations related to the share repurchase and other corporate governance matters. The document is not the reports themselves but a formal announcement of the board meeting decisions and approvals, with references to where the full reports can be found (e.g., on the designated disclosure website). The document length is about 7,290 characters, which is relatively short for full reports but appropriate for a board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. It is not an Annual Report (10-K) or Audit Report (AR) because it does not contain the full reports or detailed financial statements, only approvals and summaries. It is not a Regulatory Filing (RNS) because it is a formal board resolution announcement with detailed content. Therefore, the best classification is MANG with high confidence.
2022-03-18 Chinese
2021年度社会责任报告
Environmental & Social Information Classification · 95% confidence The document is titled '2021年度社会责任报告' which translates to '2021 Annual Social Responsibility Report' and also includes Environmental, Social, and Governance (ESG) information. It contains detailed sections on social responsibility performance, governance, environmental responsibility, employee responsibility, and community engagement. The content includes company strategy related to social responsibility, governance structure, and ESG practices. There is no indication that this is an annual financial report (10-K), audit report, or earnings release. It is a comprehensive report focused on environmental and social governance factors. Therefore, the document fits the category of Environmental & Social Information (SR). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement or a brief summary.
2022-03-18 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.